About Drug Discovery Informatics
Drug discovery informatics involves the creation of systems that can work more efficiently with large sets of clinical trial and treatment data created by the scientists when conducting research into treatments for specific diseases or for certain patient demographics.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 9.3% |
The demand for Doctor house calls is increasing. The industry is segmented, but it is predicted to grow as the rising of smart cities and the increased prevalence of OOH advertising, among other factors, drive the market forward. Businesses in this sector face global competition from market leaders who control a large share of the market. Companies are differentiating their products from the competition by employing environmentally friendly materials and manufacturing techniques. The Leading Players are engaged in strategic global expansion to maintain their Market Position. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Drug Discovery Informatics market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
IBM (United States), Infosys Ltd. (India), Schrödinger (United States), PerkinElmer (United States), Thermo Fisher Scientific (United States), GVK Biosciences (India) and Novo Informatics Pvt. Ltd. (India) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Drug Discovery Informatics market by Type (Software and Services) and Region.
On the basis of geography, the market of Drug Discovery Informatics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Function, the sub-segment i.e. Sequencing and Target Data Analysis will boost the Drug Discovery Informatics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-user, the sub-segment i.e. Pharmaceutical and Biotechnology Companies will boost the Drug Discovery Informatics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Growth Drivers:
High Demand from Pharmaceutical Companies and Increased Research and Development Activities
Challenges:
Lack of Skilled Workforce
Restraints:
High Cost Associated With Drug Discovery Informatics Software
Opportunities:
Growing Healthcare Industry Worldwide and Expirations of the Patents about Drugs
Market Leaders and their expansionary development strategies
In December 2023, Clarivate Plc announced the launch of VeriSIM Life Translational Index™ on Cortellis Drug Discovery Intelligence by Clarivate. The integrated workflow provides customers with a diverse array of predictive compound safety and efficacy insights, including bioavailability, hepatic and renal clearance, clinical toxicity, first-in-human dose and more.
In May 2023, Google Cloud announced two new AI-powered life sciences solutions to accelerate drug discovery and precision medicine for biotech companies, pharmaceutical firms, and public sector organizations. Available worldwide today, the Target and Lead Identification Suite helps researchers better identify the function of amino acids and predict the structure of proteins; and the Mult omics Suite accelerates the discovery and interpretation of genomic data, helping companies design precision treatments.
Key Target Audience
Drug Discovery Informatics Providers, Research Professionals, Emerging Companies, Government Body & Associations and End-user
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.